Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Valent

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cancer Genetics and Cytogenetics|May 14, 2003
Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse modelR M'kacher, F Farace, A Bennaceur-Griscelli, et al.
Cell|August 22, 1997
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancersM Kaghad, H Bonnet, A Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2022
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpressionC Ngo, T Grinda, A Boilève, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaP Hofman, M Ilie, V Hofman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer Genetics and Cytogenetics|May 14, 2003
Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse modelR M'kacher, F Farace, A Bennaceur-Griscelli, et al.
Cell|August 22, 1997
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancersM Kaghad, H Bonnet, A Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2022
Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpressionC Ngo, T Grinda, A Boilève, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaP Hofman, M Ilie, V Hofman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.
Pageof 5